Principles of treat-to-target (T2T) have been widely adopted in both multinational and
regional guidelines for rheumatoid arthritis (RA). Several questionnaire studies among …

Abstract Development of the treat‐to‐target (T2T) strategy, the process whereby drug
therapy is adjusted until the therapeutic goal is achieved, has revolutionized how …

Background Identification of key determinants of medication adherence may assist with
designing interventions to improve this important parameter. The aim of the study was to …

Background Rheumatoid arthritis (RA) is a chronic autoimmune disease for which prediction
of long-term prognosis from disease's outset is not clinically feasible. The importance of …

Medication adherence is believed to be a major contributor to treatment outcomes yet
studies quantifying this relationship as rare in rheumatoid arthritis (RA). To determine the …

Background: To characterise disease course and remission in a longitudinal observational
study of newly diagnosed, initially treatment-naïve patients with seropositive rheumatoid …

Objective. Compelling evidence supports a treat-to-target (T2T) strategy for optimal
outcomes in rheumatoid arthritis (RA). There is limited knowledge regarding the factors that …

Objective Patient refusal of and nonadherence to treatment with disease‐modifying
antirheumatic drugs (DMARD s) can adversely affect disease outcomes in rheumatoid …

Objective To identify and prioritize patient‐and rheumatologist‐perceived barriers to
achieving disease control. Methods Patients with rheumatoid arthritis (RA) and …

Objective. To investigate the association between adherence to treat-to-target (T2T) protocol
and disease activity, functional outcomes, and radiographic outcomes in early rheumatoid …